-
The Thomas Pocklington Trust, working with the RNIB and Glaucoma UK, has produced a video to represent how the world can look to people with vision impairment
-
The artificial intelligence system could help to predict the progression of wet age-related macular degeneration in high risk patients and even guide future preventative treatments.
-
The pharmaceutical market for age-related macular degeneration will be driven by the entry of longer-acting therapies, according to analysts at GlobalData